{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T19:57:11Z","timestamp":1781639831085,"version":"3.54.5"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Funding for Scientific Research Projects from Wuhan Municipal Health Commission","award":["WX23A86"],"award-info":[{"award-number":["WX23A86"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Mycoplasma pneumoniae pneumonia (MPP) with atelectasis in children is the most reported complication of MPP in children. It is associated with serious respiratory issues, pulmonary tissue damage and fibrosis, and systemic complications. Present diagnostic methods, which are mainly based on radiographic imaging, have drawbacks related to delayed case detection and radiation exposure. There is a need for a simple, non-invasive approach in the diagnosis. We aimed to develop machine learning (ML) models to identify MPP with atelectasis in children and support early risk stratification.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective study of 508 hospitalized pediatric patients with MPP from July 2022 to June 2024. Baseline clinical data were extracted from the electronic medical record system. Six tree-based ML models\u2014decision tree (DT), random forest (RF), adaptive boosting (ADB), extreme gradient boosting (XGB), bayesian decision tree (BDT), and neural decision tree (NDT)\u2014were developed. The SHapley Additive exPlanations (SHAP) was used to assess model feature importance, and final predictor subsets were determined through SHAP-guided forward feature selection. Models were tuned by Bayesian optimization within a nested five-fold cross-validation framework, and their performance was evaluated in an independent stratified validation cohort using receiver operating characteristic curve (AUROC), accuracy and decision curve analysis (DCA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>SHAP-guided feature selection generated a specific feature set for each model. These features reflect systemic inflammatory burden, febrile status, adaptive immune response, and target-organ injury. In the training cohort, the RF model demonstrated the best performance, achieving an AUROC of 0.91 (95% CI 0.88\u20130.93). The performance of RF remained stable in the validation cohort, with an AUROC of 0.89 (95% CI 0.83\u20130.95). The model exhibited strong classification performance across other key metrics, including sensitivity, specificity, and negative predictive value. The results suggest that the model is generalizable with minimal overfitting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The interpretable RF model helps clinicians identify early cases of MPP that is complicated with atelectasis in children. This stable and interpretable method offers a practical tool for early risk stratification and timely decision-making.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12887-026-06647-3","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T13:55:43Z","timestamp":1773064543000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["SHAP based feature selection for machine learning prediction of mycoplasma pneumoniae pneumonia with atelectasis in children"],"prefix":"10.1186","volume":"26","author":[{"given":"Mian","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tengfei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengsi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,9]]},"reference":[{"key":"6647_CR1","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1056\/NEJMoa1405870","volume":"372","author":"S Jain","year":"2015","unstructured":"Jain S, et al. Community-acquired pneumonia requiring hospitalization among US children. N Engl J Med. 2015;372:835\u201345.","journal-title":"N Engl J Med"},{"key":"6647_CR2","doi-asserted-by":"publisher","first-page":"1900112","DOI":"10.2807\/1560-7917.ES.2020.25.2.1900112","volume":"25","author":"ML Beeton","year":"2020","unstructured":"Beeton ML, et al. Mycoplasma pneumoniae infections, 11 countries in Europe and Israel, 2011 to 2016. Eurosurveillance. 2020;25:1900112.","journal-title":"Eurosurveillance"},{"key":"6647_CR3","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1002\/jmv.24963","volume":"90","author":"H Oumei","year":"2018","unstructured":"Oumei H, et al. Etiology of community-acquired pneumonia in 1500 hospitalized children. J Med Virol. 2018;90:421\u20138.","journal-title":"J Med Virol"},{"key":"6647_CR4","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1093\/cid\/ciy419","volume":"68","author":"PK Kutty","year":"2019","unstructured":"Kutty PK, et al. Mycoplasma pneumoniae among children hospitalized with community-acquired pneumonia. Clin Infect Dis. 2019;68:5\u201312.","journal-title":"Clin Infect Dis"},{"key":"6647_CR5","doi-asserted-by":"publisher","first-page":"e192","DOI":"10.1017\/S0950268819000839","volume":"147","author":"LW Gao","year":"2019","unstructured":"Gao LW, et al. The epidemiology of paediatric Mycoplasma pneumoniae pneumonia in North China: 2006 to 2016. Epidemiol Infect. 2019;147:e192.","journal-title":"Epidemiol Infect"},{"key":"6647_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12519-023-00783-x","volume":"20","author":"C Yan","year":"2024","unstructured":"Yan C, et al. Current status of Mycoplasma pneumoniae infection in China. World J Pediatr. 2024;20:1\u20134.","journal-title":"World J Pediatr"},{"key":"6647_CR7","doi-asserted-by":"publisher","first-page":"4940","DOI":"10.12998\/wjcc.v12.i22.4940","volume":"12","author":"LP Wang","year":"2024","unstructured":"Wang LP, Hu ZH, Jiang JS, Jin J. Serum inflammatory markers in children with Mycoplasma pneumoniae pneumonia and their predictive value for mycoplasma severity. World J Clin Cases. 2024;12:4940.","journal-title":"World J Clin Cases"},{"key":"6647_CR8","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12879-021-05765-w","volume":"21","author":"J Zhang","year":"2021","unstructured":"Zhang J, et al. Prediction of risk factors of bronchial mucus plugs in children with Mycoplasma pneumoniae pneumonia. BMC Infect Dis. 2021;21:67.","journal-title":"BMC Infect Dis"},{"key":"6647_CR9","volume-title":"StatPearls","author":"K Grott","year":"2025","unstructured":"Grott K, Chauhan S, Sanghavi DK, Dunlap JD, Atelectasis. StatPearls. Treasure Island (FL): StatPearls Publishing; 2025."},{"key":"6647_CR10","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s12325-019-01129-8","volume":"37","author":"DQ Su","year":"2020","unstructured":"Su DQ, Li JF, Zhuo ZQ. Clinical analysis of 122 cases with mycoplasma pneumonia complicated with atelectasis: a retrospective study. Adv Ther. 2020;37:265\u201371.","journal-title":"Adv Ther"},{"key":"6647_CR11","doi-asserted-by":"publisher","first-page":"1422074","DOI":"10.3389\/fped.2024.1422074","volume":"12","author":"M Xu","year":"2024","unstructured":"Xu M, et al. Risk association model for atelectasis complication in Mycoplasma pneumoniae pneumonia patients following standardized treatment. Front Pediatr. 2024;12:1422074.","journal-title":"Front Pediatr"},{"key":"6647_CR12","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s12890-023-02464-x","volume":"23","author":"Y Luo","year":"2023","unstructured":"Luo Y, Wang Y, Gong K. Risk prediction model for long-term atelectasis in children with pneumonia. BMC Pulm Med. 2023;23:169.","journal-title":"BMC Pulm Med"},{"key":"6647_CR13","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1007\/s00247-017-3891-0","volume":"47","author":"S Andronikou","year":"2017","unstructured":"Andronikou S, Goussard P, Sorantin E. Computed tomography in children with community-acquired pneumonia. Pediatr Radiol. 2017;47:1431\u201340.","journal-title":"Pediatr Radiol"},{"key":"6647_CR14","doi-asserted-by":"publisher","first-page":"S215","DOI":"10.1016\/j.jacr.2020.01.033","volume":"17","author":"SS Chan","year":"2020","unstructured":"Chan SS, et al. ACR appropriateness criteria\u00ae pneumonia in the immunocompetent child. J Am Coll Radiol. 2020;17:S215\u201325.","journal-title":"J Am Coll Radiol"},{"key":"6647_CR15","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/pch\/16.7.428","volume":"16","author":"TK Chibuk","year":"2011","unstructured":"Chibuk TK, et al. Paediatric complicated pneumonia: diagnosis and management of empyema. Paediatr Child Health. 2011;16:425\u20137.","journal-title":"Paediatr Child Health"},{"key":"6647_CR16","doi-asserted-by":"publisher","first-page":"448","DOI":"10.3389\/fmicb.2016.00448","volume":"7","author":"K Loens","year":"2016","unstructured":"Loens K, Ieven M. Mycoplasma pneumoniae: current knowledge on nucleic acid amplification techniques and serological diagnostics. Front Microbiol. 2016;7:448.","journal-title":"Front Microbiol"},{"key":"6647_CR17","first-page":"270","volume":"134","author":"L Zhang","year":"2011","unstructured":"Zhang L, Zong ZY, Liu YB, Ye H, Lv XJ. PCR versus serology for diagnosing Mycoplasma pneumoniae infection: a systematic review & meta-analysis. Indian J Med Res. 2011;134:270\u201380.","journal-title":"Indian J Med Res"},{"key":"6647_CR18","doi-asserted-by":"publisher","first-page":"735093","DOI":"10.3389\/fped.2021.735093","volume":"9","author":"H Zhong","year":"2021","unstructured":"Zhong H, et al. Analysis of clinical characteristics and risk factors of plastic bronchitis in children with Mycoplasma pneumoniae pneumonia. Front Pediatr. 2021;9:735093.","journal-title":"Front Pediatr"},{"key":"6647_CR19","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1007\/s00431-022-04761-9","volume":"182","author":"H Zhang","year":"2023","unstructured":"Zhang H, et al. Clinical features and risk factors of plastic bronchitis caused by refractory Mycoplasma pneumoniae pneumonia in children: a practical nomogram prediction model. Eur J Pediatr. 2023;182:1239\u201349.","journal-title":"Eur J Pediatr"},{"key":"6647_CR20","first-page":"1","volume":"9","author":"CJ Editorial Board","year":"2025","unstructured":"Subspecialty Group of Respiratory, the S. of P., Chinese Medical Association, China National Clinical Research Center of Respiratory Diseases &, Editorial Board CJ. of P. Evidence-based guideline for the diagnosis and treatment of Mycoplasma pneumoniae pneumonia in children (2023). Pediatr Investig. 2025;9:1\u201311.","journal-title":"Pediatr Investig"},{"key":"6647_CR21","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1186\/s12890-023-02766-0","volume":"23","author":"L Yang","year":"2023","unstructured":"Yang L, et al. Clinical features and risk factors of plastic bronchitis caused by Mycoplasma pneumoniae pneumonia in children. BMC Pulm Med. 2023;23:468.","journal-title":"BMC Pulm Med"},{"key":"6647_CR22","doi-asserted-by":"publisher","first-page":"e158","DOI":"10.1017\/S0950268824001134","volume":"152","author":"X Chen","year":"2024","unstructured":"Chen X, Wang S, Cai H, Xia X. The predictive values of C-reactive protein-neutrophil to lymphocyte ratio for the risk of refractory Mycoplasma pneumoniae pneumonia in children: a retrospective cohort study. Epidemiol Infect. 2024;152:e158.","journal-title":"Epidemiol Infect"},{"key":"6647_CR23","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.4187\/respcare.03920","volume":"60","author":"A Lu","year":"2015","unstructured":"Lu A, Wang C, Zhang X, Wang L, Qian L. Lactate dehydrogenase as a biomarker for prediction of refractory Mycoplasma pneumoniae pneumonia in children. Respir Care. 2015;60:1469\u201375.","journal-title":"Respir Care"},{"key":"6647_CR24","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s12931-024-02892-1","volume":"25","author":"D Wei","year":"2024","unstructured":"Wei D, Zhao Y, Zhang T, Xu Y, Guo W. The role of LDH and ferritin levels as biomarkers for corticosteroid dosage in children with refractory Mycoplasma pneumoniae pneumonia. Respir Res. 2024;25:266.","journal-title":"Respir Res"},{"key":"6647_CR25","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1002\/ppul.24684","volume":"55","author":"S Cheng","year":"2020","unstructured":"Cheng S, et al. Development and validation of a simple-to-use nomogram for predicting refractory Mycoplasma pneumoniae pneumonia in children. Pediatr Pulmonol. 2020;55:968\u201374.","journal-title":"Pediatr Pulmonol"},{"key":"6647_CR26","doi-asserted-by":"publisher","first-page":"813614","DOI":"10.3389\/fped.2022.813614","volume":"10","author":"F Shen","year":"2022","unstructured":"Shen F, et al. Development of a nomogram for predicting refractory Mycoplasma pneumoniae pneumonia in children. Front Pediatr. 2022;10:813614.","journal-title":"Front Pediatr"},{"key":"6647_CR27","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1186\/s12890-023-02684-1","volume":"23","author":"M Li","year":"2023","unstructured":"Li M, et al. Recognition of refractory Mycoplasma pneumoniae pneumonia among Mycoplasma pneumoniae pneumonia in hospitalized children: development and validation of a predictive nomogram model. BMC Pulm Med. 2023;23:383.","journal-title":"BMC Pulm Med"},{"key":"6647_CR28","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1186\/s12890-022-02047-2","volume":"22","author":"L Zhao","year":"2022","unstructured":"Zhao L, et al. Development and validation of a nomogram to predict plastic bronchitis in children with refractory Mycoplasma pneumoniae pneumonia. BMC Pulm Med. 2022;22:253.","journal-title":"BMC Pulm Med"},{"key":"6647_CR29","doi-asserted-by":"publisher","first-page":"18029","DOI":"10.1038\/s41598-025-02962-4","volume":"15","author":"Y Jiang","year":"2025","unstructured":"Jiang Y, et al. Predicting and interpreting key features of refractory Mycoplasma pneumoniae pneumonia using multiple machine learning methods. Sci Rep. 2025;15:18029.","journal-title":"Sci Rep"},{"key":"6647_CR30","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1186\/s12879-025-10958-8","volume":"25","author":"Y Ye","year":"2025","unstructured":"Ye Y, et al. A machine learning model for predicting severe Mycoplasma pneumoniae pneumonia in school-aged children. BMC Infect Dis. 2025;25:570.","journal-title":"BMC Infect Dis"},{"key":"6647_CR31","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/bjs.9736","volume":"102","author":"GS Collins","year":"2015","unstructured":"Collins GS, Reitsma JB, Altman DG, Moons KG. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. J Br Surg. 2015;102:148\u201358.","journal-title":"J Br Surg"},{"key":"6647_CR32","doi-asserted-by":"publisher","unstructured":"Collins GS, et al. TRIPOD\u2009+\u2009AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods. BMJ. 2024;385. https:\/\/doi.org\/10.1136\/bmj-2023-078378.","DOI":"10.1136\/bmj-2023-078378"},{"key":"6647_CR33","doi-asserted-by":"publisher","unstructured":"Efthimiou O, et al. Developing clinical prediction models: a step-by-step guide. BMJ. 2024;386. https:\/\/doi.org\/10.1136\/bmj-2023-078276.","DOI":"10.1136\/bmj-2023-078276"},{"issue":"1","key":"6647_CR34","first-page":"73","volume":"9","author":"S Zhao","year":"2024","unstructured":"Zhao S, et al. Guidelines for the Diagnosis and Treatment of Mycoplasma Pneumonia in Children (2023 Edition). Electron J Emerg Infect Dis. 2024;9(1):73\u20139.","journal-title":"Electron J Emerg Infect Dis"},{"key":"6647_CR35","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1177\/0962280206075304","volume":"16","author":"MG Kenward","year":"2007","unstructured":"Kenward MG, Carpenter J. Multiple imputation: current perspectives. Stat Methods Med Res. 2007;16:199\u2013218.","journal-title":"Stat Methods Med Res"},{"key":"6647_CR36","doi-asserted-by":"publisher","first-page":"100353","DOI":"10.1016\/j.health.2024.100353","volume":"6","author":"MS Shaon","year":"2024","unstructured":"Shaon MS, Karim T, Shakil MS, Hasan M. Z. A comparative study of machine learning models with LASSO and SHAP feature selection for breast cancer prediction. Healthc Anal. 2024;6:100353.","journal-title":"Healthc Anal"},{"key":"6647_CR37","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.bbe.2022.06.007","volume":"42","author":"Y Liu","year":"2022","unstructured":"Liu Y, Liu Z, Luo X, Zhao H. Diagnosis of Parkinson\u2019s disease based on SHAP value feature selection. Biocybern Biomed Eng. 2022;42:856\u201369.","journal-title":"Biocybern Biomed Eng"},{"key":"6647_CR38","doi-asserted-by":"publisher","first-page":"136758","DOI":"10.1109\/ACCESS.2023.3338369","volume":"11","author":"SC Patra","year":"2023","unstructured":"Patra SC, Maheswari BU, Pati PB. Forecasting coronary heart disease risk with a 2-step hybrid ensemble learning method and forward feature selection algorithm. IEEE Access. 2023;11:136758\u201369.","journal-title":"IEEE Access"},{"key":"6647_CR39","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1010933404324","volume":"45","author":"L Breiman","year":"2001","unstructured":"Breiman L. Random Forests. Mach Learn. 2001;45:5\u201332.","journal-title":"Mach Learn"},{"key":"6647_CR40","doi-asserted-by":"publisher","first-page":"100180","DOI":"10.1016\/j.imu.2019.100180","volume":"15","author":"MZ Alam","year":"2019","unstructured":"Alam MZ, Rahman MS, Rahman MS. A Random Forest based predictor for medical data classification using feature ranking. Inf Med Unlocked. 2019;15:100180.","journal-title":"Inf Med Unlocked"},{"key":"6647_CR41","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1006\/jcss.1997.1504","volume":"55","author":"Y Freund","year":"1997","unstructured":"Freund Y, Schapire RE. A decision-theoretic generalization of on-line learning and an application to boosting. J Comput Syst Sci. 1997;55:119\u201339.","journal-title":"J Comput Syst Sci"},{"key":"6647_CR42","doi-asserted-by":"publisher","first-page":"4730","DOI":"10.1093\/bioinformatics\/btz297","volume":"35","author":"Y Zhao","year":"2019","unstructured":"Zhao Y, Chen X, Yin J. Adaptive boosting-based computational model for predicting potential miRNA-disease associations. Bioinformatics. 2019;35:4730\u20138.","journal-title":"Bioinformatics"},{"key":"6647_CR43","doi-asserted-by":"publisher","unstructured":"Chen T, Guestrin C, XGBoost. A scalable tree boosting system. in 785\u201394 (2016). https:\/\/doi.org\/10.1145\/2939672.2939785","DOI":"10.1145\/2939672.2939785"},{"key":"6647_CR44","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41419-017-0003-x","volume":"9","author":"X Chen","year":"2018","unstructured":"Chen X, Huang L, Xie D, Zhao Q. EGBMMDA: extreme gradient boosting machine for MiRNA-disease association prediction. Cell Death Dis. 2018;9:3.","journal-title":"Cell Death Dis"},{"key":"6647_CR45","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1080\/01621459.1998.10473750","volume":"93","author":"HA Chipman","year":"1998","unstructured":"Chipman HA, George EI, McCulloch RE. Bayesian CART model search. J Am Stat Assoc. 1998;93:935\u201348.","journal-title":"J Am Stat Assoc"},{"key":"6647_CR46","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1109\/TITB.2006.880553","volume":"11","author":"V Schetinin","year":"2007","unstructured":"Schetinin V, et al. Confident interpretation of Bayesian decision tree ensembles for clinical applications. IEEE Trans Inf Technol Biomed. 2007;11:312\u20139.","journal-title":"IEEE Trans Inf Technol Biomed"},{"key":"6647_CR47","doi-asserted-by":"publisher","unstructured":"Kontschieder P, Fiterau M, Criminisi A, Bulo S. R. Deep neural decision forests. in 1467\u201375 (2015). https:\/\/doi.org\/10.1109\/ICCV.2015.172","DOI":"10.1109\/ICCV.2015.172"},{"key":"6647_CR48","first-page":"26","volume":"17","author":"J Wu","year":"2019","unstructured":"Wu J, et al. Hyperparameter optimization for machine learning models based on Bayesian optimization. J Electron Sci Technol. 2019;17:26\u201340.","journal-title":"J Electron Sci Technol"},{"key":"6647_CR49","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s13104-020-05050-0","volume":"13","author":"L Gao","year":"2020","unstructured":"Gao L, Ding Y. Disease prediction via Bayesian hyperparameter optimization and ensemble learning. BMC Res Notes. 2020;13:205.","journal-title":"BMC Res Notes"},{"key":"6647_CR50","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/EDE.0b013e3181c30fb2","volume":"21","author":"EW Steyerberg","year":"2010","unstructured":"Steyerberg EW, et al. Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology. 2010;21:128\u201338.","journal-title":"Epidemiology"},{"key":"6647_CR51","doi-asserted-by":"publisher","first-page":"51","DOI":"10.7326\/M18-1376","volume":"170","author":"RF Wolff","year":"2019","unstructured":"Wolff RF, et al. PROBAST: a tool to assess the risk of bias and applicability of prediction model studies. Ann Intern Med. 2019;170:51\u20138.","journal-title":"Ann Intern Med"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-026-06647-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-026-06647-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-026-06647-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T19:39:09Z","timestamp":1781638749000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12887-026-06647-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,9]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6647"],"URL":"https:\/\/doi.org\/10.1186\/s12887-026-06647-3","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,9]]},"assertion":[{"value":"3 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was reviewed and approved by the Ethics Committee of Wuhan Wuchang Hospital (Approval No. 2024006). Given its retrospective design and the use of de-identified existing data from the electronic medical record system, the Ethics Committee waived the requirement for informed consent. This waiver included the consent from parents or legal guardians for minor participants (under 16 years of age). The study was conducted in accordance with the ethical principles of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable (no individual person\u2019s data in any form).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"328"}}